Petros Pharmaceuticals, Inc. PTPI
0.00
(0.01)
(100.00%)
as of 25 Sep
- Market cap
- $1.0M
- P/E
- 0.0×
Follow PTPI
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(1,475.74%) | 1,900.89% | 1,085.80% | (710.28%) | |
| (356.67%) | (553.07%) | (385.60%) | (334.15%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(1,420.44%) | (1,521.79%) | (2,394.50%) | (2,608.36%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(0.11) | (0.24) | (0.13) | (0.08) | |
Free Cash Flow |
(4.84) | (6.73) | (5.86) | (3.72) | |
| Other line items | |||||
Cash ROIC |
(51.24%) | (84.10%) | (95.67%) | (88.69%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | — | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.10 | 0.15 | 0.14 | 0.20 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.11) | (0.24) | (0.13) | (0.08) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates